Susquehanna International Group’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40,096
| Closed | -$52.3K | – | 13572 |
|
|
2025
Q1 | $39.5K | Buy |
+40,096
| New | +$48.3K | ﹤0.01% | 11930 |
|
|
2024
Q3 | – | Sell |
-44,612
| Closed | -$147K | – | 12884 |
|
|
2024
Q2 | $147K | Buy |
44,612
+29,925
| +204% | +$107K | ﹤0.01% | 10713 |
|
|
2024
Q1 | $69.2K | Sell |
14,687
-12,354
| -46% | -$79.1K | ﹤0.01% | 11418 |
|
|
2023
Q4 | $197K | Sell |
27,041
-20,046
| -43% | -$112K | ﹤0.01% | 10697 |
|
|
2023
Q3 | $569K | Buy |
+47,087
| New | +$486K | ﹤0.01% | 7919 |
|
|
2023
Q2 | – | Sell |
-22,710
| Closed | -$223K | – | 12976 |
|
|
2023
Q1 | $223K | Sell |
22,710
-7,479
| -25% | -$85.8K | ﹤0.01% | 10352 |
|
|
2022
Q4 | $444K | Buy |
+30,189
| New | +$452K | ﹤0.01% | 8177 |
|
|
2022
Q1 | – | Sell |
-18,979
| Closed | -$281K | – | 13837 |
|
|
2021
Q4 | $400K | Buy |
+18,979
| New | +$447K | ﹤0.01% | 9782 |
|
|
2021
Q1 | – | Sell |
-6,303
| Closed | -$216K | – | 12760 |
|
|
2020
Q4 | $216K | Buy |
+6,303
| New | +$188K | ﹤0.01% | 9919 |
|
Susquehanna International Group's RPTX Position: Q2 2025 in Review
Susquehanna International Group sold out of Repare Therapeutics (RPTX) in Q2 2025, closing a stake of 40,096 shares — an estimated $52.3K sold.
Susquehanna International Group first reported a position in RPTX in Q4 2020 and held it in 9 quarters. The position peaked at $569K in Q3 2023. 50 funds tracked by Wall St. Rank hold RPTX as of Q2 2025.
- Susquehanna International Group reported no remaining Repare Therapeutics position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 40,096 Repare Therapeutics shares in Q2 2025, an estimated $52.3K.
- Susquehanna International Group first reported a position in Repare Therapeutics in Q4 2020 and held it in 9 quarters.
- Susquehanna International Group's Repare Therapeutics position peaked at $569K in Q3 2023.
- 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.